Is CBD legal?
Is CBD classified as an addictive/narcotic substance?
Am I allowed to buy and own CBD products?
What are the regulations for CBD?
According to the Austrian Agency for Health and Food Safety (AGES), cannabinoid-containing oils and extracts are not dietary supplements according to §3 Z 4 of the Austrian Food Safety and Consumer Protection Act (LMSVG, BGBl I no. 13/2006 idgF). For this reason, they are not encompassed by Austrian food regulation laws and may therefore not be recommended for ingestion. So far, there is no CBD-pure pharmaceutical drug approved by European officials. However, a physician may prescribe a magistral preparation (i.e. an oily solution with cannabidiol according to DAC/NRF). The prescription drug is dispensed by a pharmacist upon presentation of a health care provider`s written authorization.
I suffer from one of the reported conditions where CBD is supposed to help. Where can I find information about clinical trials, and can I participate?
All international clinical studies can be found on www.clinicaltrials.gov. The search function makes it relatively easy to find different studies. This way, you can investigate if and where a relevant study is taking place. We also recommend that you talk to a physician or pharmacist whom you trust.
How old must I be to be able to buy CBD?
To be able to buy CBD products from HANAFSAN, you must be at least 18 years old.
When should I take hemp products containing CBD, and what is the recommended amount?
Due to the legal regulations for CBD (see What are the regulations for CBD?) we are not allowed to make any statements concerning ingestion of our CBD products. We recommend that you ask your pharmacist, or a physician whom you trust, and that you read the relevant documentation.
For which complaints can I use CBD?
The significant medical benefits of CBD have been scientifically and to a certain extent also clinically proven. For instance, CBD has been given the Orphan Drug Status of the European Medicines Agency (EMA) as treatment for Dravet syndrome, as well as for the treatment of perinatal asphyxia1. In 2018, the US Food and Drug Administration (FDA) approved CBD for the treatment of Dravet and Lennox Gastaut syndrome (for patients over 2 years of age)2. In a report on CBD from the World Health Organization (WHO), it was also noted that CBD could be used for a variety of conditions and complaints (including neurodegenerative diseases, pain, and inflammation)3. In the DAC/NRF amendment of the German Pharmacopoeia, there are reports on the effects of CBD in REM sleep behavior disorder (RBD) and mention of its anti-inflammatory, anticonvulsant, antiemetic, anxiolytic, hypnotic or antipsychotic potential, which may have a rational relevance in the treatment of certain types of neuritis, epilepsy, dizziness, vomiting, anxiety and schizophrenia, as well as in connection with neurodegenerative diseases or cancer1. More information about international clinical studies can be found on www.clinicaltrials.gov. We emphasize that the described and published health claims have no connection to our HANAFSAN products.
Will I get “high” on CBD?
No. A “high” is caused by the substance THC. The cannabinoid THC is a psychoactive therapeutic active substance, regulated by the Austrian Medicinal Products Act. CBD, on the other hand, is not psychoactive.
What happens if I am stopped by the police while carrying HANAFSAN products?
We guarantee that our CBD oils and tinctures are THC-free (the definition of free being not detectable through modern analytical procedures). For the CBD flowers, we guarantee that the THC content is less than 0.3 percent. Appropriate certificates can be produced in case of doubt. The police officers are well trained and know the difference between THC and CBD products.
What is the difference between CBD hemp flowers from HANAFSAN and “marijuana”?
They come from a different hemp strain; therefore, the THC content is also different. CBD flowers from HANAFSAN come from hemp plants included in the EU Common Catalogue. Hemp varieties included in the EU Common Catalogue have a THC content of <0.3 percent and will not make you “high”, whereas the THC concentration in “marijuana” can be as high as 20 percent.
How come the explicit statement that HANAFSAN CBD products are not medicinal products is found on HANAFSAN CBD products and web pages with HANAFSAN information?
This is to ensure that the averagely informed consumer will not assign any medicinal properties (healing/relief from diseases or pathological conditions) to the products offered based on the scientifically and clinically proven health and/or disease-related statements on our CBD web page.
Typesetting and printing errors reserved. The health claims described are not related to our HANAFSAN products.
1 NRF-formulation 22.10.; (DAC/NRF 2017/2)
2 FDA news release; FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy (June 26th, 2018); www.epidiolex.com
3 WHO Report Cannabidiol (Geneva, 2017; Pisanti et al., 2017)